Effect of Personalized Elimination Diet on Food Sensitivity Related Symptoms
NCT ID: NCT05389683
Last Updated: 2024-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2023-01-02
2024-02-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
NCT03539692
Healthcare Decisions on Dietary and Environmental Allergen Exposure
NCT03144908
Food Allergy Registry at a Single Site
NCT03539705
Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis
NCT03320369
The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema
NCT00163839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Based on the test results and as per the physician's recommendations, a suitable elimination diet will be suggested to the patient. Personalized diet suggestions for each patient will be made by the physician. The patient will follow the diet for 4 weeks and blood samples will be tested again on completion of the diet, using peptides and protein microarrays. Additionally, based on the physician's recommendations, the time duration for which a patient follows the personalized elimination diet can be modified.
The patients will periodically have to fill out diagnostic questionnaires which will help assess the changes in their food sensitivity-related symptoms. Changes in the blood biomarkers and improvement in symptoms will be monitored during the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Elimination Diet
Participants will be suggested an 'Elimination diet' that will be devoid of the reaction-inducing foods and it shall be followed for 4 weeks.
Elimination Diet
An 'elimination diet' devoid of the reaction-inducing foods will be suggested for 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Elimination Diet
An 'elimination diet' devoid of the reaction-inducing foods will be suggested for 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients suffering from food sensitivity symptoms
* Patients having Immunoglobulin G (IgG) and Immunoglobulin A (IgA)-mediated food reactions leading to food sensitivity
* Patients agreeing to follow the diet per testing
* Patients willing to provide an informed consent
Exclusion Criteria
* Pregnant subjects
* Patients who have recently used antibiotics
* Patients who have previously undergone treatments for food allergies/sensitivities
* Patients who have been assigned an elimination diet before
* Patients who are already following a restricted diet of any kind
* Patients unwilling/unable to provide informed consent
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vibrant America Clinical Lab
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hari Krishnamurthy
Director - Biomedical Engineering
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hari K Krishnamurthy, M.S.
Role: PRINCIPAL_INVESTIGATOR
PI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hope Natural Health
Gilbert, Arizona, United States
Inside Out Aesthetics
Scottsdale, Arizona, United States
Vitality MD's
Scottsdale, Arizona, United States
Mr. Hari Krishnamurthy
San Carlos, California, United States
Vitality Health and Wellness
Miami Beach, Florida, United States
Institute for Hormonal Balance
Orlando, Florida, United States
One Agora Integrative Health
Bloomington, Minnesota, United States
Turnpaugh Health and Wellness Center - Manheim
Manheim, Pennsylvania, United States
Turnpaugh Health and Wellness Center - Mechanicsburg
Mechanicsburg, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB # 1-1586736-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.